0001192482-19-000447.txt : 20191126 0001192482-19-000447.hdr.sgml : 20191126 20191126191855 ACCESSION NUMBER: 0001192482-19-000447 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191122 FILED AS OF DATE: 20191126 DATE AS OF CHANGE: 20191126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhang Junge CENTRAL INDEX KEY: 0001790205 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36751 FILM NUMBER: 191252707 MAIL ADDRESS: STREET 1: 5 GREAT VALLEY PARKWAY, SUITE 160 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ocugen, Inc. CENTRAL INDEX KEY: 0001372299 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 GREAT VALLEY PARKWAY STREET 2: SUITE 160 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-328-4698 MAIL ADDRESS: STREET 1: 5 GREAT VALLEY PARKWAY STREET 2: SUITE 160 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: HISTOGENICS CORP DATE OF NAME CHANGE: 20060810 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-11-22 0001372299 Ocugen, Inc. OCGN 0001790205 Zhang Junge C/O OCUGEN, INC. 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 1 0 0 0 Common Stock 2019-11-22 4 P 0 80000 .28 A 215078 D Common Stock 2019-11-25 4 P 0 115000 .27 A 330078 D Common Stock 212863 I By Gupiao Trust The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.27 to $0.28. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.26 to $0.27. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (2) to this Form 4. /s/ Junge Zhang by Kelly Beck, his attorney-in-fact 2019-11-26